Anteris Technologies Files 8-K on Equity Sales

TL;DR

Anteris Tech filed an 8-K for equity sales & other events. Check it out.

AI Summary

Anteris Technologies Global Corp. filed an 8-K on October 27, 2025, reporting on unregistered sales of equity securities and other events. The filing indicates the company is based in Delaware and its principal executive offices are located in Eagan, MN, with a phone number of 651-493-0606. The report also lists an Australian address for its principal executive offices.

Why It Matters

This filing provides updates on the company's equity transactions and other corporate events, which could impact its financial structure and shareholder value.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate events and equity sales, not indicating immediate financial distress or significant operational changes.

Key Numbers

• 001-42437 — SEC File Number (Identifies the company's filing history with the SEC.)
• 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

• Anteris Technologies Global Corp. (company) — Registrant
• October 27, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• Eagan, MN (location) — Principal Executive Offices
• 651-493-0606 (phone_number) — Business Phone
• Toowong, QLD Australia (location) — Australian Principal Executive Offices

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share AVR The Nasdaq Global Mar
• $4.90 — shares of Common Stock at a price of US$4.90 per share of Common Stock and accompany
• $7.50 — purchase 2,788,064 CDIs at a price of A$7.50 per CDI and accompanying CDI Warrant (t
• $11.5 million — k. The Company received approximately US$11.5 million in gross proceeds from the Common Stock

Filing Documents

• ef20057753_8k.htm (8-K) — 33KB
• 0001140361-25-039496.txt ( ) — 165KB
• avr-20251027.xsd (EX-101.SCH) — 4KB
• avr-20251027_lab.xml (EX-101.LAB) — 22KB
• avr-20251027_pre.xml (EX-101.PRE) — 16KB
• ef20057753_8k_htm.xml (XML) — 4KB

02

Item 3.02. Unregistered Sales of Equity Securities. The information contained in Item 8.01 below with respect to the Additional Securities (as defined below) is incorporated by reference in this Item 3.02.

01

Item 8.01. Other Events. As previously disclosed, on October 23, 2025 (October 24, 2025 AEST), Anteris Technologies Global Corp. (the "Company") entered into (i) subscription agreements (the "Subscription Agreements") with certain investors, pursuant to which the Company agreed to sell 2,244,896 shares (the "Shares") of the Company's common stock, par value $0.0001 per share ("Common Stock"), and accompanying five-year warrants (the "Common Stock Warrants") to purchase 2,244,896 shares of Common Stock at a price of US$4.90 per share of Common Stock and accompanying Common Stock Warrant (the "Common Stock Offering"), and (ii) confirmation letters (the "Confirmation Letters") with certain investors, pursuant to which the Company agreed to sell 2,788,064 CHESS Depositary Interests ("CDIs") and accompanying five-year warrants (the "CDI Warrants") to purchase 2,788,064 CDIs at a price of A$7.50 per CDI and accompanying CDI Warrant (the "CDI Offering" and, together with the Common Stock Offering, the "Offering"). Each of the Common Stock Warrants and the CDI Warrants are exercisable commencing six months following the date of issuance. On October 24, 2025, as part of the Common Stock Offering, the Company entered into Subscription Agreements with additional investors, pursuant to which it agreed to sell an additional 102,040 Shares of Common Stock (the "Additional Shares") and accompanying Common Stock Warrants (the "Additional Common Stock Warrants" and, together with the Additional Shares, the "Additional Securities") at the same price and on the same terms as the other Shares and Common Stock Warrants sold in the Common Stock Offering. The registration statement that the Company will file with the Securities and Exchange Commission covering the covering the resale of the Shares, the shares of Common Stock issuable upon exercise of the Common Stock Warrants, the shares of Common Stock underlying the CDIs issued in the CDI Offering, and the shares of Common Stock und

Forward Looking Statements

Forward Looking Statements This Current Report on Form 8-K contains forward-looking statements. Forward-looking statements include all statements that are not historical facts. Forward-looking continue," "will likely result" and similar expressions, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described under "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal period ended December 31, 2024 that was filed with the Securities and Exchange Commission. Readers are cautioned not to put undue reliance on forward-looking

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Anteris Technologies Global Corp. Date: October 27, 2025 By: /s/ Wayne Paterson Name: Wayne Paterson Title: Vice Chairman and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR